Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 4/10

vs
industry
vs
history
Cash-to-Debt 0.05
NYSE:THC's Cash-to-Debt is ranked lower than
86% of the 243 Companies
in the Global Medical Care industry.

( Industry Median: 0.34 vs. NYSE:THC: 0.05 )
Ranked among companies with meaningful Cash-to-Debt only.
NYSE:THC' s Cash-to-Debt Range Over the Past 10 Years
Min: 0  Med: 0.04 Max: 0.35
Current: 0.05
0
0.35
Equity-to-Asset 0.02
NYSE:THC's Equity-to-Asset is ranked lower than
94% of the 241 Companies
in the Global Medical Care industry.

( Industry Median: 0.48 vs. NYSE:THC: 0.02 )
Ranked among companies with meaningful Equity-to-Asset only.
NYSE:THC' s Equity-to-Asset Range Over the Past 10 Years
Min: 0  Med: 0.17 Max: 0.43
Current: 0.02
0
0.43
Interest Coverage 1.29
NYSE:THC's Interest Coverage is ranked lower than
94% of the 218 Companies
in the Global Medical Care industry.

( Industry Median: 7.64 vs. NYSE:THC: 1.29 )
Ranked among companies with meaningful Interest Coverage only.
NYSE:THC' s Interest Coverage Range Over the Past 10 Years
Min: 0.66  Med: 1.23 Max: 1.82
Current: 1.29
0.66
1.82
Piotroski F-Score: 4
Altman Z-Score: 0.97
WACC vs ROIC
5.01%
7.81%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry
vs
history
Operating Margin % 6.38
NYSE:THC's Operating Margin % is ranked lower than
55% of the 244 Companies
in the Global Medical Care industry.

( Industry Median: 7.23 vs. NYSE:THC: 6.38 )
Ranked among companies with meaningful Operating Margin % only.
NYSE:THC' s Operating Margin % Range Over the Past 10 Years
Min: -8.66  Med: 5.82 Max: 8.21
Current: 6.38
-8.66
8.21
Net Margin % -1.06
NYSE:THC's Net Margin % is ranked lower than
80% of the 244 Companies
in the Global Medical Care industry.

( Industry Median: 4.95 vs. NYSE:THC: -1.06 )
Ranked among companies with meaningful Net Margin % only.
NYSE:THC' s Net Margin % Range Over the Past 10 Years
Min: -9.5  Med: 0.18 Max: 13.5
Current: -1.06
-9.5
13.5
ROE % -33.13
NYSE:THC's ROE % is ranked lower than
94% of the 229 Companies
in the Global Medical Care industry.

( Industry Median: 10.69 vs. NYSE:THC: -33.13 )
Ranked among companies with meaningful ROE % only.
NYSE:THC' s ROE % Range Over the Past 10 Years
Min: -124.98  Med: 2.68 Max: 92.79
Current: -33.13
-124.98
92.79
ROA % -0.88
NYSE:THC's ROA % is ranked lower than
78% of the 246 Companies
in the Global Medical Care industry.

( Industry Median: 4.67 vs. NYSE:THC: -0.88 )
Ranked among companies with meaningful ROA % only.
NYSE:THC' s ROA % Range Over the Past 10 Years
Min: -8.75  Med: 0.19 Max: 13.89
Current: -0.88
-8.75
13.89
ROC (Joel Greenblatt) % 15.00
NYSE:THC's ROC (Joel Greenblatt) % is ranked lower than
58% of the 246 Companies
in the Global Medical Care industry.

( Industry Median: 21.13 vs. NYSE:THC: 15.00 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
NYSE:THC' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: -14.52  Med: 11.28 Max: 15.25
Current: 15
-14.52
15.25
3-Year Revenue Growth Rate 30.90
NYSE:THC's 3-Year Revenue Growth Rate is ranked higher than
96% of the 175 Companies
in the Global Medical Care industry.

( Industry Median: 7.70 vs. NYSE:THC: 30.90 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
NYSE:THC' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -13.7  Med: -0.2 Max: 32.4
Current: 30.9
-13.7
32.4
3-Year EBITDA Growth Rate 20.10
NYSE:THC's 3-Year EBITDA Growth Rate is ranked higher than
78% of the 152 Companies
in the Global Medical Care industry.

( Industry Median: 6.70 vs. NYSE:THC: 20.10 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
NYSE:THC' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: -47.1  Med: 7.7 Max: 31.5
Current: 20.1
-47.1
31.5
GuruFocus has detected 4 Warning Signs with Tenet Healthcare Corp $NYSE:THC.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» NYSE:THC's 10-Y Financials

Financials (Next Earnings Date: 2017-02-27)


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

Q1 2016

THC Guru Trades in Q1 2016

David Tepper 348,405 sh (New)
George Soros 31,700 sh (New)
Mario Gabelli 15,050 sh (+0.07%)
Larry Robbins 17,890,230 sh (unchged)
Paul Tudor Jones Sold Out
Louis Moore Bacon Sold Out
» More
Q2 2016

THC Guru Trades in Q2 2016

Joel Greenblatt 545,902 sh (New)
Larry Robbins 17,890,230 sh (unchged)
George Soros Sold Out
David Tepper Sold Out
Mario Gabelli 15,000 sh (-0.33%)
» More
Q3 2016

THC Guru Trades in Q3 2016

Paul Tudor Jones 45,786 sh (New)
Steven Cohen 415,400 sh (New)
Mario Gabelli 15,000 sh (unchged)
Larry Robbins 17,890,230 sh (unchged)
Joel Greenblatt 22,489 sh (-95.88%)
» More
Q4 2016

THC Guru Trades in Q4 2016

George Soros 13,500 sh (New)
Paul Singer 1,494,358 sh (New)
Michael Price 250,000 sh (New)
Jim Simons 1,325,875 sh (New)
Larry Robbins 17,890,230 sh (unchged)
Joel Greenblatt Sold Out
Mario Gabelli Sold Out
Paul Tudor Jones 24,300 sh (-46.93%)
Steven Cohen 5,300 sh (-98.72%)
» More
» Details

Insider Trades

Latest Guru Trades with THC

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Health Care Providers » Medical Care    NAICS: 622110    SIC: 8062
Compare:NAS:SCAI, NYSE:AMN, NYSE:SEM, NAS:LPNT, NAS:AMED, OTCPK:LTGHY, NYSE:CHE, NAS:PAHC, NAS:SGRY, NYSE:CYH, NAS:TVTY, NYSE:USPH, NAS:LHCG, NYSE:HLS, NAS:PRSC, NAS:AFAM, OTCPK:MFCSF, NAS:ACHC, NAS:ADUS, NYSE:CCM » details
Traded in other countries:THC1.Germany,
Tenet Healthcare Corp is a health care services company whose subsidiaries and affiliates operate regionally focused, integrated health care delivery networks.

Tenet Healthcare Corp, a Nevada corporation was incorporated in 1975. It is an investor-owned company whose subsidiaries and affiliates operate regionally health care delivery networks with a presence in several urban and suburban markets. At the core of its networks are acute care and specialty hospitals that, together with its strategically aligned outpatient facilities and related businesses, allow them to provide a comprehensive range of health care services in the communities it serves. The Company operated 86 hospitals, 475 outpatient centers, six health plans, six accountable care networks and Conifer Health Solutions, LLC ("Conifer"), which provides business process solutions to more than 700 hospital and other clients nationwide. It provides comprehensive operational management for revenue cycle functions, including patient access, health information management, revenue integrity and patient financial services. It also offers communications and engagement solutions to optimize the relationship between providers and patients. In addition, its management services offerings have expanded to support value-based performance through clinical integration, financial risk management and population health management. For financial reporting purposes, its business lines are classified into two separate reportable business segments - hospital operations and other, and Conifer. Its subsidiaries operated 86 hospitals, including four academic medical centers, two children's hospitals, three specialty hospitals and a critical access hospital, with a total of 22,525 licensed beds, serving urban and suburban communities in 14 states. Of those hospitals, 67 were owned by its subsidiaries, and five were owned by third parties and leased by its subsidiaries. In addition, its subsidiaries operated a long-term acute care hospital and owned or leased and operated a number of medical office buildings, all of which were located on, or nearby, its hospital campuses. The Company also owns or controls six accountable care networks - in Florida, California, Illinois, Michigan and Texas - and participates in two additional accountable care networks through collaborations with other health care providers in its markets in Arizona and Massachusetts. These networks operate using a range of payment and delivery models that seek to align provider reimbursement in a way that encourages improved quality metrics and efficiencies in the total cost of care for an assigned population of patients through cooperation of the providers. The Company's health plans are subject to state and federal laws and regulations. Both federal and state government agencies continue heightened and coordinated civil and criminal enforcement efforts against the health care industry.

Ratios

vs
industry
vs
history
Forward PE Ratio 10.73
THC's Forward PE Ratio is ranked higher than
93% of the 76 Companies
in the Global Medical Care industry.

( Industry Median: 20.20 vs. THC: 10.73 )
Ranked among companies with meaningful Forward PE Ratio only.
N/A
PB Ratio 4.13
THC's PB Ratio is ranked lower than
63% of the 253 Companies
in the Global Medical Care industry.

( Industry Median: 2.73 vs. THC: 4.13 )
Ranked among companies with meaningful PB Ratio only.
THC' s PB Ratio Range Over the Past 10 Years
Min: 1.39  Med: 5.23 Max: 100.25
Current: 4.13
1.39
100.25
PS Ratio 0.11
THC's PS Ratio is ranked higher than
98% of the 256 Companies
in the Global Medical Care industry.

( Industry Median: 1.67 vs. THC: 0.11 )
Ranked among companies with meaningful PS Ratio only.
THC' s PS Ratio Range Over the Past 10 Years
Min: 0.05  Med: 0.31 Max: 0.56
Current: 0.11
0.05
0.56
Price-to-Free-Cash-Flow 3.11
THC's Price-to-Free-Cash-Flow is ranked higher than
97% of the 115 Companies
in the Global Medical Care industry.

( Industry Median: 23.76 vs. THC: 3.11 )
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
THC' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 2.06  Med: 40.46 Max: 514.15
Current: 3.11
2.06
514.15
Price-to-Operating-Cash-Flow 2.11
THC's Price-to-Operating-Cash-Flow is ranked higher than
99% of the 168 Companies
in the Global Medical Care industry.

( Industry Median: 14.75 vs. THC: 2.11 )
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
THC' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 1.31  Med: 6.52 Max: 15.63
Current: 2.11
1.31
15.63
EV-to-EBIT 13.19
THC's EV-to-EBIT is ranked higher than
79% of the 206 Companies
in the Global Medical Care industry.

( Industry Median: 20.76 vs. THC: 13.19 )
Ranked among companies with meaningful EV-to-EBIT only.
THC' s EV-to-EBIT Range Over the Past 10 Years
Min: -273.8  Med: 13.6 Max: 1337.9
Current: 13.19
-273.8
1337.9
EV-to-EBITDA 7.94
THC's EV-to-EBITDA is ranked higher than
87% of the 222 Companies
in the Global Medical Care industry.

( Industry Median: 15.90 vs. THC: 7.94 )
Ranked among companies with meaningful EV-to-EBITDA only.
THC' s EV-to-EBITDA Range Over the Past 10 Years
Min: -34  Med: 8 Max: 22.6
Current: 7.94
-34
22.6
Shiller PE Ratio 52.24
THC's Shiller PE Ratio is ranked lower than
69% of the 45 Companies
in the Global Medical Care industry.

( Industry Median: 29.68 vs. THC: 52.24 )
Ranked among companies with meaningful Shiller PE Ratio only.
THC' s Shiller PE Ratio Range Over the Past 10 Years
Min: 34.64  Med: 68.29 Max: 301.91
Current: 52.24
34.64
301.91
Current Ratio 1.13
THC's Current Ratio is ranked lower than
57% of the 238 Companies
in the Global Medical Care industry.

( Industry Median: 1.29 vs. THC: 1.13 )
Ranked among companies with meaningful Current Ratio only.
THC' s Current Ratio Range Over the Past 10 Years
Min: 1.11  Med: 1.52 Max: 2.38
Current: 1.13
1.11
2.38
Quick Ratio 1.05
THC's Quick Ratio is ranked lower than
57% of the 238 Companies
in the Global Medical Care industry.

( Industry Median: 1.15 vs. THC: 1.05 )
Ranked among companies with meaningful Quick Ratio only.
THC' s Quick Ratio Range Over the Past 10 Years
Min: 1.03  Med: 1.42 Max: 2.29
Current: 1.05
1.03
2.29
Days Inventory 8.86
THC's Days Inventory is ranked higher than
70% of the 186 Companies
in the Global Medical Care industry.

( Industry Median: 16.39 vs. THC: 8.86 )
Ranked among companies with meaningful Days Inventory only.
THC' s Days Inventory Range Over the Past 10 Years
Min: 8.86  Med: 10.47 Max: 13.35
Current: 8.86
8.86
13.35
Days Sales Outstanding 51.39
THC's Days Sales Outstanding is ranked lower than
61% of the 204 Companies
in the Global Medical Care industry.

( Industry Median: 42.10 vs. THC: 51.39 )
Ranked among companies with meaningful Days Sales Outstanding only.
THC' s Days Sales Outstanding Range Over the Past 10 Years
Min: 46.89  Med: 53.87 Max: 62.54
Current: 51.39
46.89
62.54
Days Payable 35.45
THC's Days Payable is ranked lower than
53% of the 157 Companies
in the Global Medical Care industry.

( Industry Median: 39.14 vs. THC: 35.45 )
Ranked among companies with meaningful Days Payable only.
THC' s Days Payable Range Over the Past 10 Years
Min: 35.45  Med: 48.85 Max: 56.74
Current: 35.45
35.45
56.74

Buy Back

vs
industry
vs
history
3-Year Average Share Buyback Ratio 2.00
THC's 3-Year Average Share Buyback Ratio is ranked higher than
87% of the 121 Companies
in the Global Medical Care industry.

( Industry Median: -2.50 vs. THC: 2.00 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
THC' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -12.9  Med: -0.5 Max: 7.3
Current: 2
-12.9
7.3

Valuation & Return

vs
industry
vs
history
Price-to-Intrinsic-Value-Projected-FCF 0.98
THC's Price-to-Intrinsic-Value-Projected-FCF is ranked higher than
83% of the 99 Companies
in the Global Medical Care industry.

( Industry Median: 1.79 vs. THC: 0.98 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
THC' s Price-to-Intrinsic-Value-Projected-FCF Range Over the Past 10 Years
Min: 0.67  Med: 1.19 Max: 222.62
Current: 0.98
0.67
222.62
Price-to-Median-PS-Value 0.36
THC's Price-to-Median-PS-Value is ranked higher than
96% of the 227 Companies
in the Global Medical Care industry.

( Industry Median: 1.03 vs. THC: 0.36 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
THC' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.21  Med: 1.41 Max: 5.79
Current: 0.36
0.21
5.79
Earnings Yield (Greenblatt) % 7.57
THC's Earnings Yield (Greenblatt) % is ranked higher than
83% of the 257 Companies
in the Global Medical Care industry.

( Industry Median: 3.90 vs. THC: 7.57 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
THC' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: 0.1  Med: 6.9 Max: 15.7
Current: 7.57
0.1
15.7
Forward Rate of Return (Yacktman) % 35.82
THC's Forward Rate of Return (Yacktman) % is ranked higher than
93% of the 112 Companies
in the Global Medical Care industry.

( Industry Median: 9.73 vs. THC: 35.82 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) % only.
THC' s Forward Rate of Return (Yacktman) % Range Over the Past 10 Years
Min: -103.1  Med: 0.5 Max: 38.4
Current: 35.82
-103.1
38.4

More Statistics

Revenue (TTM) (Mil) $19,787
EPS (TTM) $ -2.12
Beta1.02
Short Percentage of Float20.49%
52-Week Range $14.06 - 34.08
Shares Outstanding (Mil)99.64

Analyst Estimate

Dec16 Dec17 Dec18
Revenue (Mil $) 19,496 19,754 20,771
EPS ($) 1.16 2.01 2.50
EPS without NRI ($) 1.16 2.01 2.50
EPS Growth Rate
(Future 3Y To 5Y Estimate)
32.71%
Dividends per Share ($)
» More Articles for NYSE:THC

Headlines

Articles On GuruFocus.com
8 of the Worst Stocks in Gurus' Portfolios Feb 20 2017 
Can Universal Health Services Power Past the Political Turbulence? Nov 30 2016 
Guru, Philanthropist Larry Robbins Adds to 3 Healthcare-Related Holdings Dec 06 2015 
Insiders Buy Stock in Wynn Resorts, Bank of New York Mellon Oct 25 2015 
Larry Robbins Raises Stake in Tenet Healthcare Oct 05 2015 
Obamacare Makes HCA a Buy Aug 24 2015 
Insider Buys Round-up: Tenet Healthcare and Sprint Corp Aug 14 2015 
Distressed Debt Investor Paul Singer Buys Citrix Systems Jun 11 2015 
Humana And Concentra To Part Ways Mar 27 2015 
Tenet Healthcare And United Surgical JV For $1.93 Billion Mar 24 2015 

More From Other Websites
[$$] Tenet Healthcare Earnings: What to Watch Feb 24 2017
Tenet Healthcare (THC) Q4 Earnings: What's in the Cards? Feb 24 2017
Tenet Healthcare upgraded by Mizuho Feb 24 2017
U.S. hospital stocks start 2017 strong as some Obamacare fears ease Feb 15 2017
Lifshitz & Miller Law Firm Announces Investigation of Alcobra Ltd., Egalet Corporation, Sanderson... Feb 02 2017
Former Atlanta hospital exec indicted over Tenet bribery scheme Feb 02 2017
Ex-Tenet Healthcare executive accused by U.S. of fraud Feb 01 2017
Ex-Tenet Healthcare executive charged in fraud scheme -U.S. Justice Dept Feb 01 2017
Conifer Health to Deliver Value-Based Care Services to Alameda Health Jan 26 2017
Tenet to Report Fourth Quarter Results on February 27th Jan 26 2017
Trump's Quick Health Care Moves Have Serious Ramifications for Hospitals, Medicaid-Heavy Insurers Jan 24 2017
Cramer: The Trump Tripod Supporting the Rally Is Still Standing Jan 23 2017
Why You Should Hold onto Acadia Healthcare (ACHC) Stock Jan 20 2017
Final ruling in Fort Mill hospital battle? Jan 13 2017
American Hospitals Are Disappearing -- and Repealing Obamacare Will Make It Worse Jan 13 2017
Tenet Healthcare Corp. – Value Analysis (NYSE:THC) : January 6, 2017 Jan 06 2017
Obama's 'Last' Jobs Report Trails Estimates -- and Doesn't Help Trump Either Jan 06 2017
Tenet to Participate in the 35th Annual J.P. Morgan Healthcare Conference on January 9, 2017 Jan 05 2017
Tenet Healthcare Corp. breached its 50 day moving average in a Bullish Manner : THC-US : January 5,... Jan 05 2017

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)